William J. Ehlhardt

1.3k total citations
31 papers, 1.1k citations indexed

About

William J. Ehlhardt is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, William J. Ehlhardt has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Pharmacology and 5 papers in Organic Chemistry. Recurrent topics in William J. Ehlhardt's work include Pharmacogenetics and Drug Metabolism (9 papers), Biochemical and Molecular Research (5 papers) and Chemical Reactions and Isotopes (5 papers). William J. Ehlhardt is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Biochemical and Molecular Research (5 papers) and Chemical Reactions and Isotopes (5 papers). William J. Ehlhardt collaborates with scholars based in United States, Belgium and Canada. William J. Ehlhardt's co-authors include Palaniappan Kulanthaivel, James J. Starling, Todd M. Baughman, Robert L. Shepard, Jin Cao, Anne H. Dantzig, Thomas F. Bumol, Robert J. Barbuch, Jamie L. Renbarger and Jennifer B. Dennison and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Chemical Physics and Journal of Medicinal Chemistry.

In The Last Decade

William J. Ehlhardt

31 papers receiving 1.0k citations

Peers

William J. Ehlhardt

ONCOL

PHARM

PPCH

Hirotsune Igimi Japan

Lori H. Takahashi United States

Kimberley A. Lentz United States

Manjunath S. Shet United States

Xiaomei Zhuang China

Per Garberg Sweden

Sekhar Surapaneni United States

Gary Mather United States

Brita Sjöström Sweden

Martijn Rooseboom Netherlands

Hirotsune Igimi Japan

William J. Ehlhardt

518 ×1.1

ONCOL

371 ×0.9

93 ×0.4

PHARM

274 ×1.4

66 ×0.4

PPCH

Citations per year, relative to William J. Ehlhardt William J. Ehlhardt (= 1×) peers Hirotsune Igimi

Countries citing papers authored by William J. Ehlhardt

Since Specialization

Citations

This map shows the geographic impact of William J. Ehlhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William J. Ehlhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William J. Ehlhardt more than expected).

Fields of papers citing papers by William J. Ehlhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William J. Ehlhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William J. Ehlhardt. The network helps show where William J. Ehlhardt may publish in the future.

Co-authorship network of co-authors of William J. Ehlhardt

This figure shows the co-authorship network connecting the top 25 collaborators of William J. Ehlhardt. A scholar is included among the top collaborators of William J. Ehlhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William J. Ehlhardt. William J. Ehlhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Henry, Kenneth J., Óscar de Frutos, Pablo D. García, et al.. (2018). Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT. Bioorganic & Medicinal Chemistry Letters. 28(10). 1887–1891. 9 indexed citations

Cassidy, Kenneth C., Ivelina Gueorguieva, Colin Miles, et al.. (2017). Disposition and metabolism of [ ¹⁴ C]-galunisertib, a TGF- β RI kinase/ALK5 inhibitor, following oral administration in healthy subjects and mechanistic prediction of the effect of itraconazole on galunisertib pharmacokinetics. Xenobiotica. 48(4). 382–399. 8 indexed citations

Hu, Haitao, Ping Yi, Yu‐Hua Hui, et al.. (2015). Utilizing¹⁹F NMR to investigate drug disposition early in drug discovery. Xenobiotica. 45(12). 1081–1091. 5 indexed citations

Sun, Hao, William J. Ehlhardt, Palaniappan Kulanthaivel, et al.. (2007). Dehydrogenation of Indoline by Cytochrome P450 Enzymes: A Novel “Aromatase” Process. Journal of Pharmacology and Experimental Therapeutics. 322(2). 843–851. 34 indexed citations

Dennison, Jennifer B., Palaniappan Kulanthaivel, Robert J. Barbuch, et al.. (2006). SELECTIVE METABOLISM OF VINCRISTINE IN VITRO BY CYP3A5. Drug Metabolism and Disposition. 34(8). 1317–1327. 143 indexed citations

Reilly, Christopher A., William J. Ehlhardt, David A. Jackson, et al.. (2003). Metabolism of Capsaicin by Cytochrome P450 Produces Novel Dehydrogenated Metabolites and Decreases Cytotoxicity to Lung and Liver Cells. Chemical Research in Toxicology. 16(3). 336–349. 107 indexed citations

Soars, Matthew G., Edward L. Mattiuz, David A. Jackson, et al.. (2002). Biosynthesis of drug glucuronides for use as authentic standards. Journal of Pharmacological and Toxicological Methods. 47(3). 161–168. 21 indexed citations

Starling, James J., Robert L. Shepard, Jin Cao, et al.. (1997). Pharmacological characterization of LY335979: A potent cyclopropyldibenzosuberane modulator of P-glycoprotein. Advances in Enzyme Regulation. 37. 335–347. 70 indexed citations

Toth, John E., Gerald B. Grindey, William J. Ehlhardt, et al.. (1997). Sulfonimidamide Analogs of Oncolytic Sulfonylureas^,1. Journal of Medicinal Chemistry. 40(6). 1018–1025. 90 indexed citations

10.

Colacino, Joseph M., et al.. (1995). The Intracellular Formation of a Mononucleotide of the Anti-Influenza Agent 1,3,4-thiadiazol-2-ylcyanamide (LY217896). Antiviral chemistry & chemotherapy. 6(3). 127–137. 6 indexed citations

11.

Ehlhardt, William J., H. R. Sullivan, Paul G. Wood, et al.. (1993). Pharmacokinetics of the Anticancer Agent Sulofenur in Mice, Rats, Monkeys, and Dogs. Journal of Pharmaceutical Sciences. 82(7). 683–688. 5 indexed citations

12.

Ehlhardt, William J., et al.. (1993). Biotransformation of the antiviral agent 1,3,4-thiadiazol-2-ylcyanamide (LY217896) and characteristics of a mesoionic ribose metabolite.. Drug Metabolism and Disposition. 21(1). 162–170. 11 indexed citations

13.

Ehlhardt, William J., John F. Worzalla, Jesse R. Bewley, et al.. (1992). Comparison of metabolism and toxicity to the structure of the anticancer agent sulofenur and related sulfonylureas. Chemical Research in Toxicology. 5(5). 667–673. 13 indexed citations

14.

Ehlhardt, William J.. (1991). Metabolism and disposition of the anticancer agent sulofenur in mouse, rat, monkey, and human.. Drug Metabolism and Disposition. 19(2). 370–375. 24 indexed citations

15.

Ehlhardt, William J. & J. Jeffry Howbert. (1991). Metabolism and disposition of p-chloroaniline in rat, mouse, and monkey.. Drug Metabolism and Disposition. 19(2). 366–369. 28 indexed citations

16.

Ehlhardt, William J. & Peter Goldman. (1989). Thiol-mediated incorporation of radiolabel from 1-[14C]-methyl-4-phenyl-5-nitrosoimidazole into DNA a model for the biological activity of 5-nitroimidazoles. Biochemical Pharmacology. 38(7). 1175–1180. 6 indexed citations

17.

Ehlhardt, William J., Bernard B. Beaulieu, & Peter Goldman. (1988). Nitrosoimidazoles: highly bactericidal analogs of 5-nitroimidazole drugs. Journal of Medicinal Chemistry. 31(2). 323–329. 21 indexed citations

18.

Ehlhardt, William J., Bernard B. Beaulieu, & Peter Goldman. (1988). Mammalian cell toxicity and bacterial mutagenicity of nitrosoimidazoles. Biochemical Pharmacology. 37(13). 2603–2606. 12 indexed citations

19.

Doering, W. von E. & William J. Ehlhardt. (1987). Unsymmetrically, chemically activated 1,2-dicyclopropylacetylene: an example of restricted energy flow?. Journal of the American Chemical Society. 109(9). 2697–2706. 8 indexed citations

20.

Ehlhardt, William J., Bernard B. Beaulieu, & Peter Goldman. (1987). Formation of an amino reduction product of metronidazole in bacterial cultures: Lack of bactericidal activity. Biochemical Pharmacology. 36(2). 259–264. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact